SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,286,211 | +9.2% | 917,164 | +19.1% | 0.22% | +11.4% |
| Q2 2023 | $23,147,974 | +14.0% | 770,059 | +37.4% | 0.20% | +6.3% |
| Q1 2023 | $20,311,879 | +12.4% | 560,637 | +10.6% | 0.19% | +4.4% |
| Q4 2022 | $18,077,235 | +5.2% | 506,791 | -0.1% | 0.18% | -1.6% |
| Q3 2022 | $17,178,000 | +23.4% | 507,463 | +5.4% | 0.18% | +38.3% |
| Q2 2022 | $13,926,000 | -7.2% | 481,542 | +3.8% | 0.13% | +3.9% |
| Q1 2022 | $15,000,000 | +29.9% | 464,101 | +17.2% | 0.13% | +45.5% |
| Q4 2021 | $11,550,000 | +38.0% | 396,105 | +26.2% | 0.09% | +35.4% |
| Q3 2021 | $8,371,000 | -7.8% | 313,855 | +6.5% | 0.06% | -14.5% |
| Q2 2021 | $9,076,000 | – | 294,781 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |